In 2005, we addressed the issue of chemotherapy-related cognitive decline, sometimes called “chemo brain” or “chemo fog.” Since then, there have been some important new studies that provide more evidence of this problem, which we discuss and summarize in this new article.

Often called “chemobrain,” patients going through various cancer treatments can sometimes experience cognitive dysfunction, such as slowed thinking, memory problems, and poor coordination. In the first of two new articles in our Becoming Your Own Advocate series, we address the issue of cognitive dysfunction by discussing its causes and offering various solutions that can help prevent or minimize its effects.